Emerging role of SETD2 in the development and function of immune cells
SET domain-containing 2 (SETD2) is a methyltransferase that catalyzes trimethylation of lysine 36 on H3 (H3K36me3) in mammals, an epigenetic mark associated with actively transcribed regions. SETD2 is implicated in multiple chromatin biological processes, such as alternative splicing, transcriptiona...
Saved in:
| Main Authors: | Longmin Chen, Yuan Zou, Yan Dong, Tian Hong, Qianqian Xu, Jing Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-11-01
|
| Series: | Genes and Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304225001114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SETD2 loss of function is a recurrent event in advanced‐phase chronic myeloid leukemia and contributes to genomic instability
by: Manuela Mancini, et al.
Published: (2025-04-01) -
Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC)
by: Shafiq Shaikh, et al.
Published: (2025-12-01) -
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
by: Ryan T. Wagner, et al.
Published: (2025-02-01) -
Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
by: Kanako Hayashi, et al.
Published: (2025-08-01) -
IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming
by: Mengjia Li, et al.
Published: (2025-04-01)